The way property values are displayed:
The way concept relations are shown:
The way concept relations are shown:
Muromonab-CD3
Hierarchy: | ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Muromonab-CD3 5 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Muromonab-CD3 5 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Muromonab-CD3 5 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Muromonab-CD3 5 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Muromonab-CD3 5 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Muromonab-CD3 5 coordinate concepts∟ ∟ ∟ ∟ ∟ |
Broader terms: | |
Annotation: | do not coordinate with ANTIBODY FORMATION for biosyn
X |
History note: | Antibodies, Monoclonal (1981-1991)X |
historyNote*: | 92; MONOCLONAL ANTIBODY OKT3 was MONOCLONAL ANTIBODY OKT3, ORTHOCLONE (NM) 1987-91
X |
onlineNote*: | use MUROMONAB-CD3 (NM) to search MONOCLONAL ANTIBODY OKT3 (NM) 1987-91
X |
publicMeSHNote*: | 92; MONOCLONAL ANTIBODY OKT3 was indexed under ANTIBODIES, MONOCLONAL 1987-91
X |
Scope note: | Anti-CD3 monoclonal antibody that exerts immunosuppressive effects by inducing peripheral T-cell depletion and modulation of the T-cell receptor complex (CD3/Ti). This biochemically purified IMMUNOGLOBULIN G is obtained through the fusion of mouse myeloma cells to lymphocytes from immunized animals to produce hybridomas that secrete specific antibodies to the T3 (CD3) antigens of human T-lymphocytes. It is often used as an IMMUNOSUPPRESSIVE AGENTS in TRANSPLANTATION.
X |
activeMeSHYear*: | |
dateCreated*: | 1991-07-12X |
dateEstablished*: | 1992-01-01X |
dateRevised*: | 2005-06-30X |
recordAuthorizer*: | sjnX |
recordMaintainer*: | ssbX |
recordOriginator*: | MXRX |
Type: | |
Coordinate terms: | |
URI: | |
Labels and equivalent concepts: | Muromonabi-CD3 (fi) XMonoklonal antikropp OKT3 (sv, replaced) Orthoclone (sv, replaced) Ortho Brand of Muromonab-CD3 (en, replaced) OKT3 (en, replaced) Janssen Brand of Muromonab-CD3 (en, replaced) Monoclonal Antibody OKT3 (en, replaced) Cilag Brand of Muromonab-CD3 (en, replaced) |
Share: |
Loading results...